Ebitda 변화 날짜
AstraZeneca USD 5.16B 510M 2026-06
Genmab DKK 401M 186M 2026-06
GlaxoSmithKline GBP 3.51B 734M 2026-06
GRIFOLS EUR 473M 120M 2026-06
Hikma Pharmaceutical USD 369M 84M 2024-12
Lakefront Biotherapeutics EUR -63.7M 624.2M 2026-03
Qiagen NV USD 207.66M 59.56M 2026-06
UCB EUR 1.6B 570M 2025-12